A pharmacokinetic study of flavonoids derived from food - A pharmacokinetic study of flavonoids derived from food

Morishita Jintan Co.,Ltd.0 sites5 target enrollmentMarch 31, 2021

Overview

Phase: 未知
Intervention: Not specified
Conditions: Not specified
Sponsor: Morishita Jintan Co.,Ltd.
Enrollment: 5
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

March 31, 2021

End Date

March 31, 2021

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Morishita Jintan Co.,Ltd.

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•(1\) Subjects whose systolic blood pressure is under 90 mmHg. (2\) Subjects who fall under any of the following items; A) Subjects with heart, liver, or kidney disease (including complications of other diseases) B) Subjects with a history of cardiovascular disease C) Subjects with diabetes D) subjects with a history of gastrointestinal surgery (gastrectomy, gastrointestinal suture, intestinal resection, etc.) that may affect drug absorption E) Subjects with or suspected gastrointestinal obstruction and gastrointestinal motility F) Subjects with abnormal vomiting reflex G) Subjects with test food or drug allergies (including allergies to alcohol used to disinfect the puncture site) H) Subjects who donated 400 mL or more within 90 days, 200 mL or more within 60 days, or those who donated component blood within 30 days I) Pregnant or potentially pregnant women, and lactating women (3\) Subjects who ingested rose hips, strawberries, linden, grapefruit, foods containing St. Jones wort and dietary supplements (including supplements and beverages) within 3 days before the start of this study. (4\) Subjects who drink habitually (drinking 40 g of pure alcohol or more twice a week) or who drank within 2 days before the start of this study. (5\) Subjects who have a smoking habit and those who smoked within 2 days after the start of this study. (6\) Subjects who show a positive reaction with HBs antigen, HCV antibody, syphilis serum reaction and HIV antigen / antibody. (7\) Subjects with a lean type (BMI less than 18\.5\). (8\) Subjects who are judged to be unsuitable for the test by the investigator.